Powell Gilbert LLP

Intellectual Property

Partner specialising in intellectual property litigation. He is an experienced patent litigator who has worked on a number of the recent leading cases in the pharmaceutical and biotechnology fields. His strong life sciences background has been of particular relevance for his recent work relating to pharmaceutical, biotechnology and healthcare technologies, including vaccines, small molecule drugs, biologics, DNA sequencing, and genetic engineering. In particular, Joel has represented clients before the High Court, Court of Appeal and Supreme Court in two of the leading cases relating to the validity and infringement of second medical use (Warner-Lambert v Actavis) and biotechnology patents (Regeneron v Kymab). He has also worked on a number of electronics and mechanical engineering patent cases, and has experience of handling multi-jurisdictional patent actions. In addition to representing clients in litigation before the UK Patents Court, Court of Appeal and Supreme Court, Joel has represented clients in European Patent Office opposition proceedings, and advises on patent litigation strategies, freedom to operate, and patent term extensions, including supplementary protection certificates.

Qualified Solicitor (England & Wales) 2011; Powell Gilbert 2011 – to date; Partner 2022; Solicitor (Ireland) 2016; UPC Representative 2023.

AIPPI, EPLAW

MBiochem (Biochemistry), Oxford University; PhD (Biochemistry), Cambridge University; LLB, BPP Law School; Diploma in Intellectual Property Law and Practice, Oxford University.